746 filings
Page 2 of 38
S-8 POS
a3sclil3w9njo
9 Dec 19
Registration of securities for employees (post-effective amendment)
5:10pm
S-8 POS
fqx3dew1ro0llm2r
9 Dec 19
Registration of securities for employees (post-effective amendment)
5:10pm
S-4 POS
xwi5w8oah o87s
9 Dec 19
Post-effective amendment to a S-4EF registration statement
5:10pm
25
lba46gbd28uqt6dqy5
2 Dec 19
Voluntary exchange delisting
8:00am
8-K
d9hbasvv8rh0
22 Nov 19
Completion of Acquisition or Disposition of Assets
5:15pm
8-K
23br77k1vixm
20 Nov 19
CELGENE Announces plans to transfer listing of Celgene’s Contingent value rights following Closing of Acquisition by Bristol-Myers Squibb
5:25pm
25-NSE
454hb dtqok8yh
20 Nov 19
Exchange delisting
4:39pm
425
3nsnmtntvcurrtlqzp
15 Nov 19
Business combination disclosure
5:20pm
8-K
1jlab7qvm77io
31 Oct 19
Celgene Reports Third Quarter 2019
7:37am
8-K
z7get509n9ktj ec
26 Aug 19
Entry into a Material Definitive Agreement
7:30am
8-K
3vtt16pqp8q9odtjcomk
30 Jul 19
Celgene Reports Second Quarter 2019
7:42am
8-K
1bx5zldltl7
25 Apr 19
Celgene Reports First Quarter 2019
4:53pm
425
jtxwevnkoscdg8jr
12 Apr 19
Business combination disclosure
5:25pm
8-K
xr2mno1b kcq
12 Apr 19
Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb
4:08pm
425
4838sqfju
12 Apr 19
Business combination disclosure
4:06pm
425
ywek pug1lvcb
4 Apr 19
Business combination disclosure
4:22pm
8-K
1ljv5w9
4 Apr 19
Other Events
4:14pm